Celldex Therapeutics, Inc. - Common Stock, par value $.001 (CLDX)

Historical Holders from Q4 2018 to Q4 2025

Type / Class
Equity / Common Stock, par value $.001
Symbol
CLDX on Nasdaq
Shares outstanding
65,833,370
Price per share
$27.16
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
70,727,286
Holdings value
$1,829,751,733
% of all portfolios
0%
Share change
-1,999,380
Value change
-$41,022,173
Average buys %
+0%
Average sells %
-0%
Number of holders
177
Price from insider filings
$10.38
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Celldex Therapeutics, Inc. - Common Stock, par value $.001 (CLDX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WELLINGTON MANAGEMENT GROUP LLP 11% +40% $191,302,079 +$55,941,805 7,394,746 +41% Wellington Management Group LLP 31 Oct 2025
Kynam Capital Management, LP 9.8% +27% $103,610,000 +$22,886,540 6,500,000 +28% Kynam Capital Management, LP 31 Mar 2025
FMR LLC 7.3% $77,431,228 4,857,668 FMR LLC 31 Dec 2024
BlackRock, Inc. 7.3% -12% $76,819,530 -$10,542,349 4,819,293 -12% BlackRock, Inc. 31 Mar 2025
Point72 Asset Management, L.P. 6.7% $84,421,804 4,464,400 Point72 Asset Management, L.P. 02 Jul 2025
Bellevue Group AG 5.4% $93,589,097 3,617,669 Bellevue Group AG 18 Aug 2025
Commodore Capital LP 4.6% -8% $78,343,026 -$8,321,474 3,028,335 -9.6% Commodore Capital LP 30 Sep 2025
PRICE T ROWE ASSOCIATES INC /MD/ 3.6% -36% $61,640,475 -$30,382,633 2,382,701 -33% T. Rowe Price Associates, Inc. 30 Sep 2025
EVENTIDE ASSET MANAGEMENT, LLC 2% $30,649,804 1,356,186 Eventide Asset Management, LLC 30 Jun 2025
As of 30 Sep 2025, Celldex Therapeutics, Inc. - Common Stock, par value $.001 (CLDX) has 177 institutional shareholders filing 13F forms. They hold 70,727,286 shares .

Top 25 institutional shareholders own 90% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Kynam Capital Management, LP 9.3% 6,100,729 0% 12% $157,825,859
WELLINGTON MANAGEMENT GROUP LLP 8.8% 5,800,003 +11% 0.03% $150,046,076
BlackRock, Inc. 8.4% 5,505,988 -0.79% 0% $142,439,910
FMR LLC 7.5% 4,962,088 -8.8% 0.01% $128,369,219
VANGUARD GROUP INC 6% 3,954,590 -0.06% 0% $102,305,243
Point72 Asset Management, L.P. 5.9% 3,893,942 +39% 0.22% $100,736,290
Bellevue Group AG 5.4% 3,557,669 +7.6% 1.9% $92,036,897
Commodore Capital LP 4.6% 3,028,335 -12% 3.8% $78,343,026
STATE STREET CORP 4.3% 2,842,134 +18% 0% $73,526,007
PRICE T ROWE ASSOCIATES INC /MD/ 3.6% 2,382,518 -38% 0.01% $61,636,000
Deep Track Capital, LP 3% 2,000,000 0% 1.4% $51,740,000
EVENTIDE ASSET MANAGEMENT, LLC 2.8% 1,859,095 +37% 0.79% $48,096,095
GEODE CAPITAL MANAGEMENT, LLC 2.5% 1,647,136 -1.5% 0% $42,617,698
Polar Capital Holdings Plc 2% 1,300,436 +5.9% 0.16% $33,642,279
Pictet Asset Management Holding SA 1.8% 1,211,990 -6.8% 0.03% $31,354,181
Vestal Point Capital, LP 1.8% 1,205,000 -31% 1.4% $31,173,350
NOVO HOLDINGS A/S 1.8% 1,200,000 0% 2% $31,044,000
Eversept Partners, LP 1.8% 1,153,920 +38% 2.3% $29,851,910
GOLDMAN SACHS GROUP INC 1.6% 1,029,460 +42% 0% $26,632,130
MILLENNIUM MANAGEMENT LLC 1.5% 975,195 +104% 0.02% $25,228,295
Fisher Asset Management, LLC 1.4% 927,157 +13% 0.01% $23,985,551
AMERICAN CENTURY COMPANIES INC 1.2% 815,560 +4.6% 0.01% $21,098,594
Rock Springs Capital Management LP 1.1% 721,538 -11% 1.1% $18,666,188
BAKER BROS. ADVISORS LP 1% 665,370 0% 0.12% $17,213,122
NORTHERN TRUST CORP 0.9% 595,385 +3.4% 0% $15,402,611

Institutional Holders of Celldex Therapeutics, Inc. - Common Stock, par value $.001 (CLDX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 59,762 $1,623,382 +$845,662 $27.16 5
2025 Q3 70,727,286 $1,829,751,733 -$41,022,173 $25.87 177
2025 Q2 72,686,329 $1,479,214,886 -$18,971,939 $20.35 178
2025 Q1 73,628,376 $1,336,550,620 -$25,518,310 $18.15 170
2024 Q4 73,686,767 $1,861,794,260 -$10,935,448 $25.27 172
2024 Q3 71,809,989 $2,440,639,490 +$61,865,557 $33.99 181
2024 Q2 69,598,317 $2,575,871,087 +$1,537,961 $37.01 181
2024 Q1 69,309,919 $2,908,722,753 +$374,488,239 $41.97 197
2023 Q4 22,894 $907,976 +$170,023 $39.66 2
2023 Q3 50,571,171 $1,391,721,257 -$661,540 $27.52 139
2023 Q2 50,187,149 $1,702,920,755 +$19,492,901 $33.93 147
2023 Q1 49,499,561 $1,779,399,096 +$24,970,733 $35.98 156
2022 Q4 48,652,936 $2,168,519,107 -$3,347,309 $44.57 160
2022 Q3 48,953,228 $1,368,587,647 +$39,803,590 $28.11 142
2022 Q2 48,217,204 $1,292,783,894 -$45,839,313 $26.96 145
2022 Q1 49,600,993 $1,680,209,993 +$105,618,986 $34.06 156
2021 Q4 43,236,234 $1,660,521,385 +$98,844,683 $38.64 168
2021 Q3 43,051,243 $2,308,835,017 +$389,864,845 $53.99 155
2021 Q2 35,558,020 $1,177,699,310 +$48,015,537 $33.44 126
2021 Q1 34,501,991 $709,471,250 -$32,512,292 $20.60 110
2020 Q4 36,346,799 $636,820,871 +$70,521,771 $17.52 116
2020 Q3 32,140,544 $470,099,103 +$66,675,386 $14.83 79
2020 Q2 27,785,042 $356,422,494 +$311,412,812 $13.00 61
2020 Q1 3,914,309 $5,818,810 -$78,366 $1.66 29
2019 Q4 3,902,461 $7,907,971 +$19,411 $2.23 32
2019 Q3 3,678,427 $7,482,092 +$710,569 $2.13 38
2019 Q2 155,379 $1,539 -$443,003 $2.68 3
2019 Q1 2,602,792 $12,034,588 +$11,539,329 $4.92 38
2018 Q4 100,357 $20,000 +$20,001 $0.1993 1